Skip to content

Study of Interventional Pulmonologic Treatment of Benign Central Airway Fibrotic Stricture

Prospective, Randomized, Open, Controlled, Multicenter Stucy of Interventional Pulmonologic Treatment of Benign Central Airway Fibrotic Stricture

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02287389
Enrollment
160
Registered
2014-11-10
Start date
2014-12-31
Completion date
2017-12-31
Last updated
2014-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Airway Disease

Brief summary

The purpose of this study is to evaluate the efficacy and safety of four interventional pulmonology techniques for the treatment of fibrotic central airway stricture. The four techniques are: * balloon dilation * balloon dilation plus cryotherapy * balloon dilation plus spiculiform electrosurgery * balloon dilation plus mitomycin C injection

Interventions

PROCEDUREcryotherapy
PROCEDUREspiculiform electrosurgery
DRUGmitomycin C

Sponsors

Changhai Hospital
CollaboratorOTHER
The First Affiliated Hospital of Guangzhou Medical University
CollaboratorOTHER
Xinqiao Hospital of Chongqing
CollaboratorOTHER
China Meitan General Hospital
CollaboratorOTHER
Micro-Tech (Nanjing) Co., Ltd.
CollaboratorINDUSTRY
Tang-Du Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* tracheal incision,intubation or bronchial tuberculosis caused central airway fibrotic stenosis * the degree of stenosis is above 50% * estimated survival duration is longer than 3 months * recieved no treatment one month before * can understand the statement informed consent * agree to enroll in the study

Exclusion criteria

* older than 70 years or younger than 18 years * not fibrotic stenosis * not central airway stenosis * existence of lumina collapse or twisting * severe arrhythmia, myocardial ischemia or hypertensive crisis * coagulation disorders * existence of severe organ disfunction * allergic to anesthesia drugs * refuse to participate the study

Design outcomes

Primary

MeasureTime frame
percentage of the cases that got Ⅰand Ⅱlevel remission3 months

Secondary

MeasureTime frame
the values of dispnea index3 months
Karnofsky Physical scales3 months

Other

MeasureTime frame
adverse event during the treatment3 months

Countries

China

Contacts

Primary ContactDeguang Mu, PhD
deguang@fmmu.edu.cn86-29-84777825
Backup ContactYandong Nan, MD
nanyandong2008@163.com86-29-84717533

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026